LEN vs TMO · rev $34.19B vs P/E 24, rev $44.56B
LEN (LEN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
LEN currently screens at market cap $0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the LEN and TMO stock pages for the full models.
Not investment advice.